4 бет - Ең жақсы Көкірек қуысының рентгенографиясы дәрігерлері - ЖОҒ-177 дәрігерлер

Education and Specialization

• 1982 - 1987: Ege University Faculty of Medicine
• 1987 - 1993: İzmir Atatürk Training and Research Hospital – Specialization

Experience

• 1993 - 1996: İzmir Atatürk State Hospital – Specialist Doctor
• 1996 - 1998: İnönü University Faculty of Medicine – Assistant Professor
• 1998 - 2001: İnönü University Faculty of Medicine – Associate Professor
• 2001 - 2005: Başkent University Adana Practice and Research Hospital – Associate Professor
• 2006 - 2007: Başkent University Adana Practice and Research Hospital – Professor
• 2007 - 2013: Başkent University Istanbul Practice and Research Hospital – Professor
• 2013 - 2015: Hisar Intercontinental Hospital, Istanbul – Professor
• 2015 - Present: Acıbadem Bakırköy Hospital, Istanbul – Professor

Education and Expertise

Istanbul University Istanbul Faculty of Medicine - 2010

İstanbul Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital – Orthopedics and Traumatology – 2016

Work experiences

Private Family Hospital

Private Atakoy Hospital

Sancaktepe Health Center

Baltalimanı Bone Diseases Training and Research Hospital

Diyarbakir Selahaddin Eyyubi State Hospital

Subjects He Is Competent And Interested In:

Knee Calcification

Knee pain

Meniscus Tear

Knee Ligament Injuries

Carpal Tunnel Syndrome

Neck pain

Orthopedic Diseases

Shoulder Instability

Shoulder Dislocation

Shoulder pain

Meniscus

Recurrent Shoulder Dislocations

Hip and Knee Prosthesis

I was born in Adana in 1983. I graduated from Hacettepe University (ing) in 2007 and started to work as an orthopedic assistant at İzmir Atatürk Training and Research Hospital in 2008. I did my master's thesis on the rotator cuff healing of dicholefenac sodium. As a specialist in 2013, I started at Okmeydanı Training and Research Hospital and got my associate professorship there in 2018. In 2017, I worked as a Clinical fellow in the publication of Prof Dr Philip Lobenhoffer for Knee Circumferential Osteotomies, unicondylar and total knee arthroplasty in Germany (Go:h Sports Clinic/Hannover). I started working at Istinye University Hospital in 2019. I am married and have 2 children.

Research Areas: Knee surgery, Shoulder surgery, Ankle surgery, Artoplasty

Basic Areas: Orthopedics and Traumatology,

Awards

(2015), "Derviş Manizade Science Award", "Professional Associations", "Award received from domestic public institutions and organizations in the field", "Turkish Orthopedics and Traumatology Association", Science - Art Awards

(2017), "Tusyad Overseas Traveling Education Scholarship", "Professional Associations", "Award received from domestic public institutions and organizations in the field", "Turkish Sports Injuries Arthroscopy and Knee Surgery Association", Other

(2016), "Best Experimental Study Poster Award Winner", "Professional Associations", "Award from domestic public institutions and organizations", "Bone Joint Surgery Association", Other

(2015), "25th National Turkish Orthopedics and Traumatology Congress, first place in the poster category", "Professional Associations", "Award received from domestic public institutions and organizations in the field", "Turkish Association of Orthopedics and Traumatology Association", Work Award
 

Доктор Виола Фокс BKZ Золингендегі Гематология, Онкология және Паллиативтік медицина клиникасының бас дәрігері болып табылады. Бұл клиника сертификатталған пәнаралық қатерлі ісік орталығы. Доктор Фокс ісік ауруларын дәрі-дәрмекпен емдеуде Германия мен Еуропадағы жетекші сарапшы болып табылады. Ол осы салада 15 жылдан астам тәжірибесі бар.

Ол Германияның Онкология және Гематология-онкология Қоғамының (GDHO), Германия Дәрігерлер қауымдастығының және Американдық Қатерлі Ісік Зерттеу Қауымдастығының мүшесі болып табылады. Доктор Фокс молекулалық биология бойынша да зерттеулер жүргізеді. Оның жұмысы қатерлі ісікті емдеу мен молекулалық диагностика саласының алға жылжыуына қолдау көрсетеді.

Оның негізгі маманданған салалары химиотерапия, иммунотерапия, мақсатты терапия және радиациялық терапия болып табылады. Доктор Фокс инновациялық әдістері мен пациенттерге қамқорлық жасаудағы жоғары құлшынысымен танымал. Оның күш-жігері жоғары қалпына келу көрсеткіштерімен және әріптестерінің мойындауымен ерекшеленеді.

Dr. Pongtep Na Nakorn is a specialist in sports medicine. He focuses on shoulder and knee arthroscopic surgery.

Accreditations: Doctor of Medicine, Faculty of Medicine, Prince of Songkhla University (2007). Orthopedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University (2016). Sports Medicine, Faculty of Medicine, Thammasat University (2017).

Dr. Jirachai Pisutbenya is a spine surgeon. He specializes in endoscopic and minimally invasive spine surgery. He also treats adult spinal deformity and cervical spine disorders.

Accreditations: MD, Faculty of Medicine Ramathibodi Hospital, Mahidol University (2007). Orthopedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University (2014). Spinal Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University (2018).

Dr. Victor Alexander Krol - Chief of Gastroenterology, Internal Medicine and Obesity Treatment Center at Martinus Hospital

Dr. Victor Alexander Krol is a highly qualified specialist, heading the departments of gastroenterology and internal medicine. With many years of experience and deep knowledge in his field, Dr. Krol has established himself as an outstanding expert, providing patients with comprehensive treatment and an individual approach. He actively uses the latest methods of diagnosis and treatment of diseases of the gastrointestinal tract, metabolism, as well as diseases of the cardiovascular and respiratory systems.

Dr. Krol is also the director of the certified Obesity Treatment Center at Martinus Hospital, which provides surgical and endoscopic treatments for obesity. The center uses advanced technology to diagnose and treat obesity (adiposis), including methods such as bariatric surgery, endoscopic weight loss, and specialized programs for patients with different stages of obesity. The center is certified to high standards and has excellent results in the treatment of this serious disease.

The Gastroenterology Department, headed by Dr. Krol, diagnoses and treats diseases of the stomach, intestines, liver, pancreas, and gallbladder. The doctors of the department use a wide range of methods, including endoscopic procedures, ultrasound, and other modern diagnostic technologies.

The Department of Internal Medicine covers a wide range of diseases, including cardiology, diabetology, infectology, and therapy of respiratory and renal diseases. Dr. Krol and his team provide a comprehensive approach to treatment using the most advanced methods of medicine.

Thanks to his high professionalism and humane approach to each patient, Dr. Krol deservedly enjoys the respect of colleagues and patients.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Dr. med. Sven Rogmans is an experienced Orthopaedic and Joint Replacement Surgeon with over 28 years in clinical practice. He treats osteoarthritis using both conservative and surgical methods. He is skilled in minimally invasive hip joint replacement and manages lower limb periprosthetic fractures.

Dr. Rogmans graduated from Ruprecht-Karls-Universität in Heidelberg, Germany. He is known for his advanced arthroscopic surgery for sports injuries. He has published many articles in national and international medical journals, showing his dedication to research and progress in orthopaedics.

Dr. Marc Ulrich Becher is an interventional cardiologist and heart failure specialist at Städtisches Klinikum Solingen. He is known for performing advanced procedures such as coronary angiography, radiofrequency ablation with 3D mapping, carotid angioplasty, and stenting.

Dr. Becher’s clinic carries out about 3,000 to 4,000 diagnostic and therapeutic procedures each year. These include complex coronary interventions, catheter-based valve replacements, and structural heart procedures. He is experienced in using advanced imaging techniques like IVUS and OCT for accurate diagnosis and treatment planning.

Dr. Becher is dedicated to providing thorough and compassionate care. He uses modern therapies for both acute and chronic cardiovascular diseases, focusing on patient safety and positive outcomes.

Education:

• Degree: Faculty of Medicine, Trakya University, 2009
• Medical Specialty: Internal Medicine, Bakırköy Dr. Sadi Konuk Training and Research Hospital, 2010-2014
• Specialist Doctor: Internal Medicine, Kanuni Sultan Süleyman Training and Research Hospital, 2014-2019
• Specialist Doctor: Internal Medicine, Turkish Hospital Internal Medicine Clinic, Qatar, 2019-2020
• Specialist Doctor: Internal Medicine, Istanbul Medipol University Hospital Mega Hospital Internal Medicine Department, 2020-2024
• Associate Professor Doctor: Internal Medicine, Istanbul Medipol University Medipol Acıbadem Regional Hospital, 2024-Present.

Roles in Projects:

Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.

Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.

Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.

Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).

Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.

1997 - 2002 Ыстамбұл университетінің Джеррахпаша медицина факультеті, ортопедия және травматология бөлімі

1990 - 1996 Ыстамбұл университетінің Джеррахпаша медицина факультеті

Оның жазған және үлес қосқан мақалалары;

Перинденезді тромбоциттерге бай плазма инъекциясының тендинопатияларды емдеудегі клиникалық тиімділігі: ретроспективті зерттеу Айбарс Кыврак* (а), Мехмет Джан Үнлу (а), Эшреф Терзи (а), Олгар Бирсель (б), Дорук Акгүн (с), Юсуф Пиринджи (д), Гөкхан Кайнак (а), Ысык Акгүн (e)ацетабулярлы сүйек жетіспеушілігі бар науқастарда ацетабулярлы ревизияда ацетабулярлы төбе сақинасы мен Бурч-Шнайдер анти-протузио торының орта және ұзақ мерзімді әсерлері хат-хабар: Юсуф Пиринджи, Мұхаммед Таха Демир, Мүәммәт Сәлі, Фахри Ердоған, Нежат Гүней

Дамыған ересек жамбас дисплазиясындағы проксималды жамбас сүйегінің өлшемдік өзгермелілері Crowe IV түріндегі жамбасы бар пациенттер үшін конустық, тікбұрышты, престеу дизайны оңтайлы таңдау болуы мүмкін екенін көрсетеді

Мамандандырулар

Аяқ-қолды ұзартыу 

Спорттық хирургия

Менискус жыртылуы

Алдыңғы айқас байламының жыртылуы

Тізе протезі

Жамбас протезі

Иық протезі

Иық слапын қалпына келтіру

Биіктігін ұлғайту

Ісік хирургиясы

Аяқ хирургиясы (Hallux Valgus)

Қант диабеттік аяқ

Сүйек инфекциялары (Остеомиелит)

Experience

On his return from London, he organized and directed the Arrhythmia Unit of the Cardiology Service of the University Hospital Nuestra Señora del Pino in Las Palmas until 2000.

He later became Deputy Director of the Arrhythmia Department and Director of the Electrophysiology Laboratory at the Jimenez Diaz Foundation in Madrid.

Professor of Cardiology at the Autonomous University and Director of the North American Society of Pacing and Electrophysiology (Heart Rhythm Society) Fellowship Program, positions he held for 6 years before moving to the Quironsalud University Hospital of Madrid in 2006.

Dr. Cabrera has been head of the cardiology department at the Quironsalud University Hospital of Madrid since its opening in 2006.

Since January 2013, he has also been Head of the Cardiology Department at the Ruber Juan Bravo Hospital Complex and, in 2022, Head of Service at the new Olimpia Center.

He is a professor at the European University of Madrid, where he heads the Department of Clinical and Fundamental Translational Cardiology.

Qualification

Doctorate in Medicine and Surgery from the Faculty of Medicine of the University of Granada. From 1994 to 1996 he completed postgraduate training as an interventional cardiologist in the Arrhythmia Unit (Cardiac Electrophysiology Laboratory) of the Jiménez Díaz Foundation in Madrid.

Senior Research Fellow. National Heart and Lung Institute. Royal Brompton. Paediatric Heart Morphology under the direction of Prof. Robert H. Anderson in London (UK) in 1997.

Research and Teaching

Member of the Spanish Society of Cardiology, SEC Arrhythmia Section, European Society of Cardiology, Arrhythmia Working Group, European Heart Rhythm Association, North American Society of Pacing and Electrophysiology.

He serves on numerous committees for the selection and monitoring of fellowships and research projects of various national and international cardiology and cardiac arrhythmia societies.

Reviewer of articles for publication in the most relevant journals in the specialty. Journal of the Spanish Society of Cardiology, Heart Rhythm, Journal of Cardiovascular Electrophysiology, PACE, Europace, Heart Circulation, Journal of the American College of Cardiology, Electrophysiology of Circulation, Journal of Interventional Cardiovascular Electrophysiology.

Member of the European Society of Cardiology

Member of the Arrhythmia Working Group

European Society of Cardiology

Member of the Arrhythmia Section of the Spanish Society of Cardiology.

Member of the European Society of Cardiology (FESC)

Member of the European Heart Rhythm Association.

Member of the Selection and Control Committee of the Spanish Society of Cardiology. Post-Residency Research Training Fellowships 2001-2002/2002-2003.

Evaluator and member of the selection committee for research, technological development and innovation projects of the Government of Extremadura. Ministry of Education, Science and Technology (2001-2004).

Member of the Spanish research group. Integrated Action Programme between Spain and the United Kingdom. Directorate General of Higher Education and Research (reference HB 1998-0030). Project title: Anatomical study of the cavities of the human heart and its application to clinical electrophysiology.

Member of the Spanish research group. Integrated Action Programme between Spain and Austria. Directorate General for Higher Education and Research (reference HU 1999-0002). Project title: Electromorphological analysis of the terminal crest and posterior pectineus muscle. Its importance as a morphological substrate in different types of supraventricular tachycardias.

Participation in the clinical commission and protocol of the study AZIMILIDE versus SOTALOL on programmed cardioversion in patients with atrial fibrillation. 2001-2003.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Experience

1989 - 1990

Diyarbakır Kulp Merkez Sağlık Ocağı

1990

Selçuk University Faculty of Medicine

1995

Konya State Hospital

1995

Selçuk University Faculty of Medicine

1997

600-Bed Golcuk Naval Hospital

1999

Selçuk University Meram Faculty of Medicine

2005

Selçuk University Meram Faculty of Medicine

2011

Selçuk University Selçuklu Faculty of Medicine

2020

Özel Bower Hospital

Education

1994 Selçuk University, Thoracic Surgery

1989 Gazi University, Faculty of Medicine

1989 Gazi University, Faculty of Medicine

Cardiology Department 

Education and Specialty: 

2003 - Medical Education, School of Medicine, Çukurova University 

2009 – Specialty, School of Medicine, Uludağ University 

2015- Associate Professor, Adana Training and Research Hospital 

Experience: 

2012 - 2015 – Head of Educational and Administrative Affairs, ENT Clinic, Haseki Training and Research Hospital (3 years) 

2009 – 2011, Conscription, Şevket Yılmaz Training and Research Hospital, Bursa 

2011-2013 Bursa State Hospital 

2013-2015 Seyhan Practice Hospital, Adana Training and Research Hospital 

2015-2016 Head of Department of Cardiology, Okmeydanı Training and Research Hospital 

February 2016 – July 2019, Head of Department of Cardiology, School of Medicine, Biruni University. 

Fields of Specialties: 

Complex Coronary Interventions 

Complex Peripheral Interventions 

Pacemaker Procedures 

Electrophysiological Study and Ablation 

Heart Valve Interventions (TAVI, Mitraclip, Mitral Balloon) 

Certificates: 

Board Certificate, European Society of Cardiology 

Board Certificate, Turkish Society of Cardiology 

Professional Memberships- Number Insignificant: 

1. European Society of Cardiology 

2. Turkish Society of Cardiology 

3. Member of Istanbul Medical Chamber 

Personal motto: Your heart is entrusted to us 

Researches and Articles: 

Articles published in international peer-review journals: 

1. *Uçar H*, Gür M, Koyunsever NY, Seker T, Türkoglu C, Kaypakli O, Sahin DY, Elbasan Z, Cayli M. Mean platelet volume is independently associated with renal dysfunction in stable coronary artery disease. Platelets (ISI). 2013 Jun; 25(4):274-278. doi: 10.3109/09537104.2013.805406. Epub 2013 Jun 17 

A2. *Uçar H*, Gür M, Yildirim A, Börekçi A, Gözükara MY, Seker T, Kaypakli O, Türkoglu C, Ozaltun B, Akyol S, Harbalioglu H, Sahin DY, Elbasan Z, Cayli M. Increased Aortic Stiffness Predicts Contrast-Induced Nephropathy in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Angiology (ISI). 2014 Oct;65(9):806-11. doi: 10.1177/0003319713504126. Epub 2013 Sep 26. 

A3. *Uçar H*, Gür M, Kivrak A, Koyunsever NY, Seker T, Akilli RE, Türkoglu C, Kaypakli O, Sahin DY, Elbasan Z, Tanboga HI, Cayli M. High-sensitivity cardiac troponin T levels in newly diagnosed hypertensive patients with different left ventricle geometry. Blood Pressure (ISI). 2014 Aug;23(4):240-7. doi: 10.3109/08037051.2013.840429. Epub 2013 Sep 23. 

A4. *Uçar H*, Mustafa Gür M, Gözükara MY, Kıvrak A, Kolcu Z, Akyol S, Kaypaklı O, Elbasan Z, Sahin DY, Türkoglu C, Seker T, Çaylı M. Relationship between mean platelet volume and morning blood pressure surge in newly diagnosed hypertensive patients. The Anatolian Journal of Cardiology (ISI). 2014 Apr 8. doi: 10.5152/akd.2014.5196. [Epub ahead of print]. 

A5. *Uçar H*, Gür M, Seker T, Kaypaklı O, Elbasan Z, Koyunsever NY, Türkoglu C, Özaltun B, Kuloglu O, Kalkan GY, Sahin DY, Çaylı M. High-Sensitivity Cardiac Troponin T is Associated with SYNTAX Score and Diabetes Mellitus in Patients with Stable Coronary Artery Disease. Journal of Clinical & Experimental Cardiology , 2013 Jun; 4(9):1-5. doi: 10.4172/2155-9880.1000263 

A6. *Uçar H*, Gür M, Gözükara MY, Kalkan GY, Baykan AO, Türkoğlu C, Kaypakl O, Seker T, Sen O, Selek S, Cayl M. Gamma glutamyl transferase activity is Independently associated with oxidative stress rather than SYNTAX score. Scand J Clin Lab Invest (ISI). 2014 Sep 2:1-6. [Epub ahead of print] 

A7. *Uçar H*, Gür M, Börrekçi A, Yıldırım A, Baykan AO, Kalkan GY,Koç M, Şeker T, Coşkun M, Şen Ö, Çaylı M. Relationship between extent and complexity of coronary artery disease and different left ventricular geometric patterns in patients with coronary artery disease and hypertension. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5747 

A8. Çaylı M, Elbasan Z, Gür M, Şeker T, *Uçar H*, Kuloğlu O, Şen O, Şahin DY, Yüksel Kalkan G. Modified flower petal technique in the treatment of isolated ostial left main and non-left main bifurcation lesions. Eurointervention. Accepted 2014 Oct. 20140324-02-R2 

A9. Baykan AO, Yüksel Kalkan G, Gür M, *Uçar H*, Acele A, Seker T, Sen O, Kaypakli O, Harbalioğlu H, Cayli M. Coronary Flow Velocity Reserve in Patients with Ascending Aorta Aneurysm. Echocardiography (ISI). 2014 Oct 7. doi: 10.1111/echo.12782. [Epub ahead of print] 

A10. Şeker T, Gür M, *Uçar H*, Türkoğlu C, Baykan AO, Özaltun B, Harbalıoğlu H, Kalkan GY, Kaypaklı O, Kuloğlu O, Şen Ö, Koç M, Çaylı M. Lower serum 25-hydroxyvitamin D level is associated with impaired myocardial performance and left ventricle hypertrophy in newly diagnosed hypertensive patients. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5637 

A11. Gözükara MY, Börekçi A, Gür M, Aksoy N, Seker T, Kaypaklı O, *Uçar H*, Türkoğlu C, Koç M, Makca I, Akyol S, Selek S, Caylı M. Gamma Glutamyl Transferase Activity is Associated With Both Paraoxonase Activity and Aortic Stiffness in Hypertensive Patients. J Clin Lab Anal (ISI). 2014 Aug 17. doi: 10.1002/jcla.21785. [Epub ahead of print] 

A12. Kalkan GY, Gür M, Baykan AO, *Uçar H*, Elbasan Z, Şahin DY, Koç M, Börekçi A, Çaylı M. Mean platelet volume is associated with aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. The Anatolian Journal of Cardiology (ISI). DOI:10.5152/akd.2014.5576 

A13. Gür M, Türkoglu C, Taskın A, *Uçar H*, Börekçi A, Seker T, Gözükara MY, Kaypaklı O, Akyol S, Selek S, Sahin DY, Elbasan Z, Çayli M. Paraoxonase 1 activity and oxidative stress in patients with anterior ST elevation myocardial infarction undergoing primary percutaneous coronary intervention with and without no-reflow. Atherosclerosis (ISI). 2014 Jun;234(2):415-20. doi: 10.1016/j.atherosclerosis.2014.03.005. Epub 2014 Apr 3. 

A14. Sahin DY, Gür M, Elbasan Z, Kırım S, *Uçar H*, Seker T, Kaypaklı O, Uysal OK, Kıvrak A, Koyunsever NY, Akıllı RE, Caylı M. NT-proBNP predicts impaired myocardial function in newly diagnosed hypertensive patients with preserved ejection fraction. Clinical and Experimental Hypertension (ISI). 2014;36(5):289-94. doi: 10.3109/10641963.2013.810234. Epub 2013 Jul 18. 

A15. Caylı M, Gür M, Kalkan GY, Elbasan Z, Sahin DY, Koyunsever NY, Türkoglu C, Seker T, Kaypaklı O, Harbalıoglu H, Uçar. Gamma glutamyl transferase activity: Relationship with thoracic aortic intima media thickness and inflammation. Herz (ISI). 2014 Sep;39(6):761-766. Epub 2013 Aug 11. 

A16. Çaylı M, Gür M, Elbasan Z, Seker T, Türkoglu C, Kaypaklı O, Sahin DY, *Uçar H*, Kıvrak A, Koyunsever NY, Sen Ö. High-sensitivity cardiac troponin T predicts nondipper hypertension in newly diagnosed hypertensive patients. J Clin Hypertens (Greenwich) (ISI). 2013 Oct;15(10):731- 6. doi: 10.1111/jch.12176. Epub 2013 Aug 7. 

A17. Kalkan GY, Gür M, Baykan AO, Koyunsever NY, Kaypakli O, Sen O, Kuloglu O, Seker T, *Uçar H*, Akyol S, Elbasan Z, Sahin DY, Çayli M. Serum bilirubin level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. Angiology (ISI). 2014 Apr;65(4):308-12. doi: 10.1177/0003319713507627. Epub 2013 Oct 24. 

A18. Gür M, *Uçar H*, Kuloglu O, Kıvrak A, Seker T, Türkoglu C, Ozaltun B, Kaypaklı O, Sahin DY, Elbasan Z, Tanboga HI, Caylı M. Estimated glomerular filtration rate is associated with both arterial stiffness and N-terminal pro-brain natriuretic peptide in newly diagnosed hypertensive patients. Clinical and Experimental Hypertension (ISI). 2014;36(6):374-9. doi: 10.3109/10641963.2013.827703. Epub 2014 Jan 16. 

A19. Gür M, Caylı M, *Uçar H*, Elbasan Z, Sahin DY, Gözükara MY, Selek S, Koyunsever NY, Seker T, Türkoglu C, Kaypaklı O, Aksoy N. Paraoxonase (PON1) activity in patients with subclinical thoracic aortic atherosclerosis. Int J Cardiovasc Imaging (ISI). 2014 Jun;30(5):889-95. doi: 10.1007/s10554-014-0407-y. Epub 2014 Apr 4. 

A20. Budak YU, Huysal K, Polat M, Tarakçi G, *Uçar H*. Evaluation of the Steelex M600H coagulometer prothrombin time-international normalized ratio assay with Steelex test reagents. Biochem Med (Zagreb) (ISI). 2012 Jan; 22: 121-126 pp. 

A21. Seker T, Türkoglu C, *Uçar H*, Gür M, Sahin DY, Caylı M. Treatment of totally occluded aortic coarctation using a covered stent. Herz (ISI). 2014 Mar; DOI: 10.1007/s00059-013-3984-y [Epub ahead of print] 

A22. Börekçi A, Gür M, Türkoğlu C, Çaylı M, Selek S, Kaypaklı O, *Uçar H*, Coskun M, Seker T, Koç M, Gökdeniz T, Gözükara MY. Oxidative Stress and Paraoxonase 1 Activity Predict ContrastInduced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology (ISI). 2014 May; DOI: 10.1177/0003319714533588 [Epub ahead of print] 

A23. Kalkan GY, Gür M, Haydardedeoglu FE , Sinan Kırım S, Baykan AO, Kuloglu O, *Uçar H*, Sahin DY, Elbasan Z, Seker T, Turkoglu C, Yildirim A, Cayli M. The Association between Aortic Distensibility and Coronary Flow Reserve in Newly Diagnosed Diabetic Patients. Echocardiography (ISI). 2014 May; DOI: 10.1111/echo.12631 [Epub ahead of print] 

A24. Kalkan GY, Gür M, Koyunsever NY, Seker T, Gözükara MY, *Uçar H*, Kaypaklı O, Baykan AO, Akyol S, Türkoglu C, Elbasan Z, Sahin DY, Çaylı M. Serum 25-hydroxyvitamin D level and aortic intima-media thickness in patients without clinical manifestation of atherosclerotic cardiovascular disease. Journal of Clinical Laboratory Analysis (ISI). 2014 Aug 17. doi: 10.1002/jcla.21770. [Epub ahead of print]. 

A25. *Uçar H*, Karaagaç K, Serdar OA, Yetkin ZA, Aktürk Y, Karaagaç EU, Sarıcaoglu H, Arterial Elasticity Measurement in Patients with Behçet Disease. HealthMED (2012’ de ISI) 2012 May; 6: 3255-3261 pp. 

A26. Karaagaç K, *Uçar H*, Karaagaç E, Yetkin ZA, Aktürk Y. The Relation Betwen Aspirin Resistance and Mean Platelet Volume in Patients with Significant Coronary Artery Stenosis. HealthMED (2012’ de ISI) 2012 May ;6: 3701-3705 pp. 

A27. Cander S, Coban S Altuner S, Gül ÖÖ, Yetgin ZA, Akkurt A, *Uçar H*, Tuncel E. Prevalence and Correlates of Erectile Dysfunction in Type 2 Diabetes Mellitus: A Cross-Sectional SingleCenter Study Among Turkish Patients. Metabolic Syndrome and Related Disorders (ISI). 2014 Aug;12(6):324-9. doi: 10.1089/met.2013.0150. Epub 2014 Mar 25. 

A28. Abalı G, *Uçar H*, Elbasan Z , Gür M ,Seker T, Koyunsever NY, Çaylı M, Akpınar O. Effect of Statin on Neutrophil to Lymphocyte Ratio in Patients with Coronary Artery Disease. Experimental & Clinical Cardiology (ISI). 2014 May 

A29. Effect of fasting on 24-h blood pressure values of individuals with no previous history of hypertension. Seker A, Demirci H, Ocakoglu G, Aydin U, Ucar H, Yildiz G, Yaman O. Blood Press Monit. 2017 Oct;22(5):247-252. doi: 10.1097/MBP.0000000000000244 

A30. The importance of the neutrophil-to-lymphocyte ratio in patients with hypertrophic cardiomyopathy. Ozyilmaz S, Akgul O, Uyarel H, Pusuroglu H, Gul M, Satilmisoglu MH, Bolat I, Ozyilmaz I, *Uçar H*, Yildirim A, Bakir I. Rev Port Cardiol. 2017 Apr;36(4):239-246. doi: 10.1016/j.repc.2016.09.014. Epub 2017 Mar 18. English, Portuguese 

A31. A case of stent thrombosis presenting as acute myocardial infarction related to right coronary artery originating from the left coronary system. Ermis E, Kahraman S, Ucar H, Allahverdiyev S. Intractable Rare Dis Res. 2018 Feb;7(1):58-60. doi: 10.5582/irdr.2018.01001. 

A32. Triple Coronary Artery Thrombosis Presenting as Acute Anterior ST-Segment Elevation Myocardial Infarction. Ermis E, Kahraman S, Ucar H, Ozyılmaz SO, Allahverdiyev S. Int J Angiol. 2018 Dec;27(4):223-226. doi: 10.1055/s-0037-1608959. Epub 2017 Dec 12 

A33. Relationship between blood pressure variability and cognitive function in geriatric hypertensive patients with well-controlled blood pressure. Yıldırım E, Ermis E, Allahverdiyev S, Ucar H, Yavuzer S, Yavuzer H, Cengiz M. Aging Clin Exp Res. 2019 Feb 1. doi: 10.1007/s40520- 019-01141-6. 

C2. Book chapters written in other languages: 

C2.1. Hung JS, Lau KW, *Uçar H*, Çaylı M, Çaylı M, Practical Handbook: Practical Handbook of Advanced Interventional Cardiology (Inoue balloon mitral valvuloplasty),437-473 pp, Adana / Turkey, Çukurova Nobel Medical Bookstore, 2014 

C2.2. Feldman T, Nguyen TN, *Uçar H*, Çaylı M, Çaylı M, Practical Handbook: Practical Handbook of Advanced Interventional Cardiology (retrograde percutaneous aortic valvuloplasty), 475-486 pp, Çukurova, Adana / Turkey, Çukurova Nobel Medical Bookstore, 2014 

D. Articles published in local peer-review journals: 

D1. *Uçar H*, Gür M, Seker T, Sahin DY, Kalkan GY, Türkoglu C, Yıldırım A, Kaypaklı O, Elbasan Z, Çaylı M. Impaired kidney function is associated with syntax scorein patients with stable coronary artery disease. Archive of Turkish Society of Cardiology, 2014; DOI: 10.5543/tkda.2014.67790 

D2. Kalkan GY, Gür M, Elbasan Z, Baykan AO, Kuloğlu O, Sahin DY, Seker T, Haydardedeoglu FE, Şen Ö, *Uçar H*, Kırım S, Çayli M. Left Ventricle Geometry Affects Coronary Flow Reserve in Diabetic Patients. Archive of Turkish Society of Cardiology, Doi: 10.5543/tkda.2015.59432 

D3. *Uçar H*, Karaagaç K, Tiryakioglu S. Woven Left Coronary Artery: A Case Report. Turkish Clinics Journal of Medical Research-Case Reports 2014 (22), 5-6 pp. 

D4. Albayrak S, Kemal Karaagaç K, Baran I, Yetgin ZA, *Uçar H*, Aydınlar A, "Carvedilol and Metoprolol in Acute Myocardial Infarction Early Effect of Oxidized LDL and Paraoxonase-1 Activity Abant Medical Journal 2013; DOI: 10.5505/abantmedj.2013.30592 

D5. Gür AK, Eker E, Akyol A, Akdag S, Kolcu Z, Odabası D, *Uçar H*. Useage of Intra-aortic Baloon Pump in the Open Heart Surgeries. Medical Journal of School of Medicine, Harran University 2014 (11), 10-14 pp. 

D6. Aktürk Y, Dilek Yesilbursa D, *Uçar H*, Yücel E, Özdabakoglu O, Eryılmaz S, Sensoy B, Serdar OA, Aydınlar A. The Effect of Diurnal Blood Pressure Change on Heart Rate Recovery After Cardiac Stress Testing in Hypertensive Patients Receiving Treatment. Uludağ University, School of Medicine Journal 2008 (34), 9-13 pp. 

D7. Yesilbursa D, Aydinlar A, Karaagaç K, *Uçar H*, Aktürk Y, Yetgin ZA. Comparison of Depression and Anxiety Levels in Patients With Acute Coronary Syndrome. Journal of Clinical and Analytical Medicine 2014; DOI: 10.4328/JCAM.1443 

D8. Emül A, Karaagaç K, Yetgin ZA, *Uçar H*, Baran I, Aydınlar A. The Effects of Metabolic Syndrome on Aortic Distensibility in Patients with Angiographically Normal Coronary Arteries. Sakarya Medical Journal 2013; DOI: 10.5505/sakaryamj.2013.69672 

D9. Assessment of side branch patency using a jailed semi-inflated balloon technique with coronary bifurcation lesions. Ermiş E, *Uçar H*, Demirelli S, İpek E, Gür M, Çaylı M. Archive of Turkish Society of Cardiology 2018 Jul;46(5):340-348. doi: 10.5543/tkda.2018.47347.